Forventes på lager: 08-02-2019
While the book primarily addresses ADCs for solid tumors, the last chapter explores the emerging interest in using ADCs to treat other diseases. The therapeutic rationale of ADCs is strong: to direct small molecules to the desired site of action (and away from normal tissues) by conjugation to antibodies or other targeting moieties.
| Forlag | Springer Nature Switzerland AG |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | Softcover Reprint of the Original 1st 2018 ed. |
| Udgivelsesdato | 08-02-2019 |
| Første udgivelsesår | 2019 |
| Serie | Cancer Drug Discovery and Development |
| Illustrationer | 52 Illustrations, color; 18 Illustrations, black and white |
| Fagredaktør | Marc Damelin |
| Originalsprog | Switzerland |
| Sideantal | 357 |
| Indbinding | Paperback / softback |
| Forlag | Springer Nature Switzerland AG |
| Sideoplysninger | 357 pages, 52 Illustrations, color; 18 Illustrations, black and white |
| Mål | 235 x 155 |
| ISBN-13 / EAN-13 | 9783030086275 |